Platinum-doublet Chemotherapy and Nivolumab for the Treatment of Subjects With Neuroendocrine Neoplasms (NENs) of the Gastroenteropancreatic (GEP) Tract or of Unknown (UK) Origin.
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Gastroenteropancreatic Neuroendocrine Tumor
- Neuroendocrine Neoplasm
- Neuroendocrine Tumors
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03980925
- Collaborators
- Not Provided
- Investigators
- Study Chair: Rocío García-Carbonero, MD, PhD Hospital Universitario 12 de Octubre Study Chair: Maria del Carmen Riesco-Martínez, MD, PhD Hospital Universitario 12 de Octubre
Get Well Soon